Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane.
Some organic anions are absorbed from the gastrointestinal tract through carrier-mediated transport mechanism(s), which may include proton-coupled transport, anion exchange transport, and others. However, the molecular identity of the organic anion transporters localized at the apical membrane of human intestinal epithelial cells has not been clearly demonstrated. In the present study, we focused on human organic anion transporting polypeptide OATP-B and examined its subcellular localization and functionality in the small intestine. Localization of OATP-B was determined by immunohistochemical analysis. Transport properties of estrone-3-sulfate and the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin by OATP-B-transfected human embryonic kidney 293 cells were measured. OATP-B was immunohistochemically localized at the apical membrane of intestinal epithelial cells in humans. Uptake of [3H]estrone-3-sulfate and [14C]pravastatin by OATP-B at pH 5.5 was higher than that at pH 7.4. [3H]Estrone-3-sulfate transport was decreased by pravastatin, aromatic anion compounds, and the anion exchange inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid, but not by small anionic compounds, such as lactic acid and acetic acid. The inhibitory effect of pravastatin on the uptake of [3H]estrone-3-sulfate was concentration-dependent, and the IC50 value was 5.5 mM. The results suggested that OATP-B mediates absorption of anionic compounds and its activity may be optimum at the acidic surface microclimate pH of the small intestine. Accordingly, OATP-B plays a role in the absorption of anionic compounds across the apical membrane of human intestinal epithelial cells, although it cannot be decisively concluded that pH-dependent absorption of pravastatin is determined by OATP-B alone.
Department of Molecular Biopharmaceutics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Tokyo, Japan.
Daisuke
D
Kobayashi
Takashi
T
Nozawa
Kozue
K
Imai
Jun-ichi
J
Nezu
Akira
A
Tsuji
Ikumi
I
Tamai
D001692:Biological Transport; D002250:Carbon Radioisotopes; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D004970:Estrone / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007150:Immunohistochemistry; D007421:Intestine, Small / Q000378:metabolism*; D027361:Organic Anion Transporters / Q000378:metabolism*; D017035:Pravastatin / Q000493:pharmacokinetics; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D013997:Time Factors; D014316:Tritium
D002250:Carbon Radioisotopes; D027361:Organic Anion Transporters; D019275:Radiopharmaceuticals; C450859:SLCO2B1 protein, human; D014316:Tritium; D004970:Estrone; D017035:Pravastatin; C017296:estrone sulfate